课题基金 / 基金详情

THE T-CELL RESPONSE TO ANTIGEN

THE T-CELL RESPONSE TO ANTIGEN
T 细胞对抗原的反应
批准号:
6632442
负责人:
HARVEY CANTOR
金额:
$28.93万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-04-01 至 2005-03-31

项目摘要

项目成果

HARVEY CANTOR的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A gene product that may play an early and critical role in these responses is a T-cell cytokine we have cloned termed Eta-1 (for Early T-lymphocyte activation-1). This gene has the following features: the Eta-1 gene is the most abundant newly-transcribed mRNA species expressed after TCR ligation, encoding a secreted phosphoprotein that leads to macrophage activation and chemotactic migration in vitro and in vivo and may account for genetic resistance to several intracellular pathogens. Overexpression of Eta-1 may play a central role in the pathogenesis of autoimmune disease in MRL/lpr mice. Our recent studies indicate that mice deficient in Eta-1 gene expression secondary to targeted gene mutation fail to develop DTH responses and associated Th1-driven autoimmunity after viral infection. These defective immune responses are associated with diminished in vivo production of IL-12 and excessive production of IL-10. This in vivo response may reflect an interaction between the N- terminal portion of Eta-1 and its integrin receptor, alphavbeta3, leading to IL-12 secretion and inhibition of IL-10 expression. These findings identify Eta-1 as a critical and non-redundant cytokine that initiates Th1 inflammatory responses and provide a mechanism by which T-cell recognition of foreign antigens may govern the development of antimicrobial inflammatory responses. We propose structure/function studies to define the molecular interaction between Eta-1 and macrophage receptor(s) (SA1) and subsequent intracellular events (SA2) that regulate IL-12/IL-10 gene expression. We also propose studies to define the role of Eta-1 in Th1/DTH development to conventional antigen (SA3) and its contribution to Th1-dependent responses to microbiological pathogens and organ-specific autoimmune disease (SA4).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunologic mechanisms that prevent autoimmunity
  • 批准号:
    10265652
  • 项目类别:
  • 资助金额:
    $40.78万
  • 财政年份:
    2020
  • 负责人:
    HARVEY CANTOR
  • 依托单位:
THE T-CELL RESPONSE TO ANTIGEN
  • 批准号:
    6374616
  • 项目类别:
  • 资助金额:
    $27.37万
  • 财政年份:
    2000
  • 负责人:
    HARVEY CANTOR
  • 依托单位:
Regulation of the follicular T-cell response to autoimmunity
  • 批准号:
    10066305
  • 项目类别:
  • 资助金额:
    $42.95万
  • 财政年份:
    2000
  • 负责人:
    HARVEY CANTOR
  • 依托单位:
THE T-CELL RESPONSE TO ANTIGEN
  • 批准号:
    6511531
  • 项目类别:
  • 资助金额:
    $28.12万
  • 财政年份:
    2000
  • 负责人:
    HARVEY CANTOR
  • 依托单位:
海外基金